Welcome to the Bioquell Media/Press Centre. On our site you’ll find quick, easy access to Bioquell's technology and details of our global operations.
Be sure to check in regularly for the latest updates. And if you need more information, please contact Martin Whiting, Marketing Director and Press Communications on email@example.com or by telephone +44 (0)1264 835 835.
Complete press kits are available on request.
Bioquell welcomes clarification of biocide regulations by HSE
23 September 2016
Leading bio-decontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant.
Colistin resistant Klebsiella pneumonia outbreak in Chinese Hospital
A group of Chinese clinicians have reported an outbreak of MCR-1 producing Klebsiella pneumonia in a paediatric leukaemia ward.
UK investment into a promising new type of cancer treatment.
A large 30 million pound investment will be used to form a spin-out biopharma company called Autolus
US Company AMRI to acquire two manufacturing sites from pharmaceutical services company Aptuit.
In a $60 million deal Amri has bought Aptuit’s Glasgow aseptic manufacturing site plus its Indiana, US-based solid-state chemistry business.